Suxin Li
No. 1 East Jianshe Road
Zhengzhou, 450052, China
Zhengzhou, 450052, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
circ_0046599 Promotes HCC Progression by Competing with miR-1322 to Enhance NT5DC2 Expression.
Journal: Journal of Cancer
Published: September 14, 2024
LMNB1/CDKN1A Signaling Regulates the Cell Cycle and Promotes Hepatocellular Carcinoma Progression.
Journal: Current cancer drug targets
Published: December 18, 2023
A Predictive Model Based on the FBXO Family Reveals the Significance of Cyclin F in Hepatocellular Carcinoma.
Journal: Frontiers in bioscience (Landmark edition)
Published: December 15, 2023
Prognostic prediction and immune infiltration analysis based on ferroptosis and EMT state in hepatocellular carcinoma.
Journal: Frontiers in immunology
Published: October 21, 2022
GSG2 promotes tumor growth through regulating cell proliferation in hepatocellular carcinoma.
Journal: Biochemical and biophysical research communications
Published: July 10, 2022
A Comparison of Splenic Pathologic Change and Immune Function in HBV-Related Portal Hypertension and Chinese Budd-Chiari Syndrome Patients with Hypersplenism.
Journal: Viral immunology
Published: February 27, 2020
Analysis of risk factors of Budd-Chiari syndrome complicated with hepatocellular carcinoma
Journal: Zhonghua wai ke za zhi [Chinese journal of surgery]
Published: September 12, 2015
Studies on Budd-chiari syndrome complicated with hepatocellular carcinoma: most patients without inferior vena cava obstruction.
Journal: International journal of clinical and experimental medicine
Published: March 02, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026